Covered recipient · General Payments record
MADHUMATHI RAO
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2022–2024
$9,153.17
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $7,700.00 | 1 |
| Travel and Lodging | $667.46 | 2 |
| Food and Beverage | $622.79 | 9 |
| Education | $39.80 | 5 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Kyowa Kirin, Inc. | $8,636.57 | 8 |
| Amgen Inc. | $250.37 | 7 |
| Radius Health, Inc. | $108.11 | 1 |
| Ascendis Pharma Inc | $35.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $7.96 | 05/16/2024 | Education | Undisputed | 01/23/2026 | 1111684530 | CMS |
| Amgen Inc. | $7.96 | 05/16/2024 | Education | Undisputed | 01/23/2026 | 1111684532 | CMS |
| Amgen Inc. | $7.96 | 05/16/2024 | Education | Undisputed | 01/23/2026 | 1111684534 | CMS |
| Amgen Inc. | $7.96 | 05/16/2024 | Education | Undisputed | 01/23/2026 | 1111684536 | CMS |
| Amgen Inc. | $7.96 | 05/16/2024 | Education | Undisputed | 01/23/2026 | 1111684538 | CMS |
| Amgen Inc. | $116.88 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111684528 | CMS |
| Amgen Inc. | $93.69 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117662617 | CMS |
| Ascendis Pharma Inc | $35.00 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133847552 | CMS |
| Kyowa Kirin, Inc. | $119.11 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127036186 | CMS |
| Kyowa Kirin, Inc. | $226.86 | 08/09/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1127036188 | CMS |
| Kyowa Kirin, Inc. | $440.60 | 08/09/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1127036192 | CMS |
| Kyowa Kirin, Inc. | $50.00 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127036184 | CMS |
| Kyowa Kirin, Inc. | $25.00 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127036190 | CMS |
| Kyowa Kirin, Inc. | $25.00 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127036196 | CMS |
| Kyowa Kirin, Inc. | $50.00 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127036198 | CMS |
| Kyowa Kirin, Inc. | $7,700.00 | 09/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1127036194 | CMS |
| Radius Health, Inc. | $108.11 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089970997 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.